These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22540147)

  • 1. Characterization of the heparin-binding site of the protein z-dependent protease inhibitor.
    Yang L; Ding Q; Huang X; Olson ST; Rezaie AR
    Biochemistry; 2012 May; 51(19):4078-85. PubMed ID: 22540147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin is a major activator of the anticoagulant serpin, protein Z-dependent protease inhibitor.
    Huang X; Rezaie AR; Broze GJ; Olson ST
    J Biol Chem; 2011 Mar; 286(11):8740-51. PubMed ID: 21220417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basis for the specificity and activation of the serpin protein Z-dependent proteinase inhibitor (ZPI) as an inhibitor of membrane-associated factor Xa.
    Huang X; Dementiev A; Olson ST; Gettins PG
    J Biol Chem; 2010 Jun; 285(26):20399-409. PubMed ID: 20427285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin activation of protein Z-dependent protease inhibitor (ZPI) allosterically blocks protein Z activation through an extended heparin-binding site.
    Huang X; Swanson R; Olson ST
    J Biol Chem; 2022 Jun; 298(6):102022. PubMed ID: 35551912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contributions of basic amino acids in the autolysis loop of factor XIa to serpin specificity.
    Rezaie AR; Sun MF; Gailani D
    Biochemistry; 2006 Aug; 45(31):9427-33. PubMed ID: 16878977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of factor Xa residues critical for interaction with protein Z-dependent protease inhibitor: both active site and exosite interactions are required for inhibition.
    Rezaie AR; Manithody C; Yang L
    J Biol Chem; 2005 Sep; 280(38):32722-8. PubMed ID: 16079143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a heparin-binding site on the catalytic domain of factor XIa: mechanism of heparin acceleration of factor XIa inhibition by the serpins antithrombin and C1-inhibitor.
    Yang L; Sun MF; Gailani D; Rezaie AR
    Biochemistry; 2009 Feb; 48(7):1517-24. PubMed ID: 19178150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the protein Z-dependent protease inhibitor interactive-sites of protein Z.
    Qureshi SH; Lu Q; Manithody C; Yang L; Rezaie AR
    Biochim Biophys Acta; 2014 Sep; 1844(9):1631-7. PubMed ID: 24960590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid oxidation inactivates the anticoagulant function of protein Z-dependent protease inhibitor (ZPI).
    Huang X; Liu B; Wei Y; Beyea R; Yan H; Olson ST
    J Biol Chem; 2017 Sep; 292(35):14625-14635. PubMed ID: 28717005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic characterization of the protein Z-dependent protease inhibitor reaction with blood coagulation factor Xa.
    Huang X; Swanson R; Broze GJ; Olson ST
    J Biol Chem; 2008 Oct; 283(44):29770-83. PubMed ID: 18768472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermodynamic and kinetic characterization of the protein Z-dependent protease inhibitor (ZPI)-protein Z interaction reveals an unexpected role for ZPI Lys-239.
    Huang X; Zhou J; Zhou A; Olson ST
    J Biol Chem; 2015 Apr; 290(15):9906-18. PubMed ID: 25713144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A computational modeling and molecular dynamics study of the Michaelis complex of human protein Z-dependent protease inhibitor (ZPI) and factor Xa (FXa).
    Chandrasekaran V; Lee CJ; Lin P; Duke RE; Pedersen LG
    J Mol Model; 2009 Aug; 15(8):897-911. PubMed ID: 19172319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering a protein Z-dependent protease inhibitor (ZPI) mutant as a novel antagonist of ZPI anticoagulant function for hemophilia treatment.
    Huang X
    J Thromb Haemost; 2019 Oct; 17(10):1655-1660. PubMed ID: 31423718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for catalytic activation of protein Z-dependent protease inhibitor (ZPI) by protein Z.
    Huang X; Yan Y; Tu Y; Gatti J; Broze GJ; Zhou A; Olson ST
    Blood; 2012 Aug; 120(8):1726-33. PubMed ID: 22786881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory properties of the P1 Tyr variant of antithrombin.
    Yang L; Manithody C; Qureshi SH; Rezaie AR
    Biochemistry; 2010 Mar; 49(12):2680-6. PubMed ID: 20184328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of basic residues of the D and H helices in heparin binding to protein C inhibitor.
    Neese LL; Wolfe CA; Church FC
    Arch Biochem Biophys; 1998 Jul; 355(1):101-8. PubMed ID: 9647672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the protein Z-dependent protease inhibitor.
    Han X; Fiehler R; Broze GJ
    Blood; 2000 Nov; 96(9):3049-55. PubMed ID: 11049983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein Z-dependent protease inhibitor (ZPI) is a physiologically significant inhibitor of prothrombinase function.
    Huang X; Swanson R; Kroh HK; Bock PE
    J Biol Chem; 2019 May; 294(19):7644-7657. PubMed ID: 30918026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein Z-dependent protease inhibitor binds to the C-terminal domain of protein Z.
    Rezaie AR; Bae JS; Manithody C; Qureshi SH; Yang L
    J Biol Chem; 2008 Jul; 283(29):19922-6. PubMed ID: 18502758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residues of the 39-loop restrict the plasma inhibitor specificity of factor IXa.
    Yang L; Rezaie AR
    J Biol Chem; 2013 May; 288(18):12692-8. PubMed ID: 23530052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.